Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

3 terminated/withdrawn out of 15 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

33%

5 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

6(46.2%)

Phase 4

3(23.1%)

Phase 3

2(15.4%)

Phase 2

2(15.4%)

13Total

N/A(6)

Phase 4(3)

Phase 3(2)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT07530744Not ApplicableNot Yet Recruiting

Post-Market Registry of Transbronchial Cryo-assisted RFA During Routine Standard Bronchoscopic Tumor Stagng and Resection

Role: lead

NCT05942833Not ApplicableRecruiting

Quality of Life in Acute Complicated and Chronic Recurrent Left-sided Diverticulitis

Role: collaborator

NCT07170761Active Not Recruiting

Biomarkers and Event Patterns of Vascular Disease in Hemodialysis

Role: collaborator

NCT04600921Phase 3Terminated

Ertugliflozin to Reduce Arrhythmic Burden in ICD/CRT patientS (ERASe-Trial) - a Phase III Study

Role: collaborator

NCT06391892Phase 3Recruiting

Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery

Role: lead

NCT04591860Not ApplicableNot Yet Recruiting

A Prospective Randomised Multi - Center Trial on the Repair of Large Hiatal Hernias: Absorbable Mesh vs. Pledgeted Sutures vs. Sutures Only

Role: collaborator

NCT02120482Not ApplicableTerminated

Combined Apheresis for ABO-incompatible Transplantation - a Pilot Study

Role: collaborator

NCT02732626Not ApplicableCompleted

The Low Voltage Guided Ablation Trial of Persistent Atrial Fibrillation

Role: collaborator

NCT04793061Unknown

Circulating Tumor DNA as Marker for Response to Antineoplastic Treatment of Metastatic Cancer (FLUIDO)

Role: lead

NCT01119300Phase 4Completed

EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin

Role: collaborator

NCT01119261Phase 4Completed

EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol

Role: collaborator

NCT01119274Phase 4Completed

EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon

Role: collaborator

NCT01053884Phase 2Terminated

Anidulafungin in Patients With Hematologic Malignancies

Role: lead

NCT01281410Not ApplicableUnknown

Inspiratory Muscle Training in Patients Receiving Allogenic Stem Cell Transplantation

Role: lead

NCT00890422Phase 2Unknown

Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine

Role: lead

All 15 trials loaded